ELEDON PHARMACEUTICALS INC. - COMMON STOCK

Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection

25 Mar 2024 15:56:42 By Nasdaq GlobeNewswire

Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human

21 Mar 2024 09:31:12 By Nasdaq GlobeNewswire

Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

13 Feb 2024 18:01:00 By Nasdaq GlobeNewswire

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook

04 Jan 2024 15:40:44 By Nasdaq GlobeNewswire

Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 Dec 2023 17:00:00 By Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference

29 Nov 2023 15:05:00 By Nasdaq GlobeNewswire

Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results

09 Nov 2023 15:01:00 By Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Present at Jefferies London Healthcare Conference

08 Nov 2023 15:05:00 By Nasdaq GlobeNewswire

Eledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation

02 Nov 2023 08:05:00 By Nasdaq GlobeNewswire

Eledon Pharmaceuticals Strengthens Leadership Team with Appointment of Eliezer Katz, M.D., FACS as Chief Medical Officer

23 Oct 2023 06:00:00 By Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Present Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Society of Nephrology Kidney Week 2023 Annual Meeting

13 Oct 2023 06:00:00 By Nasdaq GlobeNewswire

Eledon Pharmaceuticals Appoints Kidney Transplant Specialist Dr. Allan Douglas Kirk to Board of Directors

02 Oct 2023 06:00:00 By Nasdaq GlobeNewswire

Eledon Pharmaceuticals Announces Use of Tegoprubart anti-CD40L Antibody in Second-ever Transplant of Genetically Modified Heart from a Pig to a Human

25 Sep 2023 06:00:00 By Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Participate at the 2023 Cantor Fitzgerald Global Healthcare Conference

20 Sep 2023 15:05:00 By Nasdaq GlobeNewswire

Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors

11 Sep 2023 06:00:00 By Nasdaq GlobeNewswire

Eledon Pharmaceuticals Announces Publication of Data Showing Treatment with Tegoprubart Promotes Kidney and Islet Allograft Survival and Function in Nonhuman Primates

06 Sep 2023 06:00:00 By Nasdaq GlobeNewswire

Eledon Pharmaceuticals Announces Dosing of 10th Patient in Ongoing Phase 1b Trial Evaluating Tegoprubart in Patients Undergoing Kidney Transplantation

16 Aug 2023 06:00:00 By Nasdaq GlobeNewswire

Eledon Pharmaceuticals Reports Second Quarter 2023 Operating and Financial Results

10 Aug 2023 06:00:01 By Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Present at Jefferies Healthcare Conference

02 Jun 2023 07:00:00 By Nasdaq GlobeNewswire

Eledon Pharmaceuticals Reports First Quarter 2023 Operating and Financial Results

11 May 2023 15:01:01 By Nasdaq GlobeNewswire